当前位置:

首 页 > 新闻资讯 > 泰莱华顿和沃辛顿合并:一样的产品性能
目录导航 Directory

泰莱华顿和沃辛顿合并:一样的产品性能News

泰莱华顿和沃辛顿合并:一样的产品性能
发布时间:2017-11-02 点击次数:557次

Taylor-Wharton泰来华顿和Worthington Industries并购,产品型号并未改变,但品牌标识做了转变,而泰莱华顿的原产品线和新产品线的并存,导致有2-3年的产品标识过渡期,相同的型号,相同的品质,不同的品牌标识并不影响客户使用体验。

美国Taylor Wharton泰来华顿液氮罐是美国历史zui悠久的,仍在运营的金属制品公司,其历史可以追溯到1742年。早期的产品包括有给乔治华盛顿*生产的炮弹; 美国登月宇航员背负设备中所用的罐体及管道。其生产厂部位于Alabama阿拉巴马州的Theodore西奥多。 CryoScience深冷科技部门早在1957就开始生产液氮生物深低温容器。经过一系列的技术发展和时间的检验,现在产品系列涵盖深低温气相/液相液氮存储罐,干式液氮运输罐,液氮杜瓦补充罐等所有行业需求类别。

Worthington Industries (沃辛顿工业WI),总部在Ohio俄亥俄州的Columbus哥伦布。公司成立于1955年,发展却十分迅猛。现在是市值40亿美金的纽约上市公司 (NYSE WOR) 。是全球的平轧钢和压力容器等工业产品制造商,拥有上万名员工,5000多个客户,83个分支机构,遍布全球11个国家。

2015年底, Worthington Industries完成了对Taylor-Wharton CryoScience的并购。现在经过两者强强联合,成立历史背景悠久,科技力量先进和资金实力雄厚的WORTHINGTON INDUSTRIES LIFE SCIENCES部门,现邀您一起加入生命科学探索之旅。

附,WI并购TW公告

OVEMBER 23, 2015

WORTHINGTON TO ACQUIRE TAYLOR WHARTON CRYOSCIENCE BUSINESS

 

COLUMBUS, OH – November 23, 2015 - Worthington Industries, Inc. (NYSE: WOR) announced today that its Cryogenics business in the Pressure Cylinders segment is purchasing the assets of the global CryoScience business of Taylor Wharton, including a manufacturing facility in Theodore, Ala. Worthington will also acquire certain other inlectual property and manufacturing assets of Taylor Wharton focused on the cryogenic industrial and LNG markets. The asset purchase is being made pursuant to the Chapter 11 bankruptcy proceedings of Taylor Wharton for $33.25 million and is expected to close on or about Dec. 7. 
 
The CryoScience product line includes cryogenic biologic specimen storage, dewars/shippers, controls and data management solutions for global biomedical research and development, healthcare, bio-banking, pharmaceutical, biotechnology and animal husbandry markets. The business also distributes products through warehouses located in Germany and Australia.
 
“This purchase extends our cryogenic capabilities into new, global end markets in life science and healthcare,” said Sean Murray, general manager of Worthington’s Cryogenics business. “Taylor Wharton began manufacturing its CryoScience product in 1957 and has developed a robust portfolio of quality products and a strong distribution network in the bioscience space, which we plan to grow. We are also excited about the U.S. manufacturing platform the Alabama facility affords us as we grow in cryogenic industrial gas and LNG.”
 
Worthington plans to leverage the manufacturing assets of the Theodore, Ala., facility to produce hydrogen, industrial gas and LNG cryogenic transport trailers that are currently being produced in its Boston facility (formerly James Russell Engineering), and eventually move all transport trailer production to Alabama. In the future, this facility could also provide industrial and LNG products such as bulk, microbulk and engineered systems for gas and liquid applications in markets including energy production, industrial fabrication and manufacturing, and hydrogen distribution.
 
About Worthington Industries
Worthington Industries is a leading global diversified metals manufacturing company with 2015 fiscal year sales of $3.4 billion.  Headquartered in Columbus, Ohio, Worthington is North America’s premier value-added steel processor providing customers with wide ranging capabilities, products and services for a variety of markets including automotive, construction and agriculture; a global leader in manufacturing pressure cylinders for industrial gas and cryogenic applications, CNG and LNG storage, transportation and alternative fuel tanks, oil and gas equipment, and brand consumer products for camping, grilling, hand torch solutions and helium balloon kits; and a manufacturer of operator cabs for heavy industrial equipment; laser welded blanks for light weighting applications; automotive racking solutions; and through joint ventures, complete ceiling grid solutions;  automotive tooling and stampings; and steel framing for commercial construction. Worthington employs approximay 10,000 people and operates 83 facilities in 11 countries. 
 
Safe Harbor Statement
The Company wishes to take advantage of the Safe Harbor provisions included in the Private Securities Litigation Reform Act of 1995 (the “Act"). Statements by the Company relating to its ability to increase market participation, expand and integrate capacity, increase efficiencies and reduce lead time, achieve growth in general and in specific markets, and other statements which are not historical information constitute "forward looking statements" within the meaning of the Act. All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from those projected. Factors that could cause actual results to differ materially include risks described from time to time in the Company's filings with the Securities and Exchange Commission.

上一篇 生物样本库标准化建设标准 下一篇 黑科技:5000万℃高温容器竟与超低温-269℃同时共存

联系人:周英
电话:
021-31009858
手机:
15900994998
  • 点击这里给我发消息